Cutaneous reactions following booster dose of COVID-19 mRNA vaccination: What we should know?
作者信息
Potestio Luca, Villani Alessia, Fabbrocini Gabriella, Martora Fabrizio
机构信息
Section of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II, Napoli, Italy.
出版信息
J Cosmet Dermatol. 2022 Nov;21(11):5339-5340. doi: 10.1111/jocd.15331. Epub 2022 Sep 20.
Abstract
摘要
相似文献
1
Cutaneous reactions following booster dose of COVID-19 mRNA vaccination: What we should know?新冠病毒mRNA疫苗加强针后的皮肤反应：我们应该了解什么？
J Cosmet Dermatol. 2022 Nov;21(11):5339-5340. doi: 10.1111/jocd.15331. Epub 2022 Sep 20.
2
Reactogenicity of Simultaneous COVID-19 mRNA Booster and Influenza Vaccination in the US.美国同时接种 COVID-19 mRNA 加强针和流感疫苗的反应原性。
JAMA Netw Open. 2022 Jul 1;5(7):e2222241. doi: 10.1001/jamanetworkopen.2022.22241.
3
A population-based assessment of myocarditis after messenger RNA COVID-19 booster vaccination among adult recipients.mRNA COVID-19 加强疫苗接种后成年受种者心肌炎的基于人群评估。
Int J Infect Dis. 2023 Jun;131:75-78. doi: 10.1016/j.ijid.2023.03.027. Epub 2023 Mar 24.
4
Evaluation of potential adverse events following COVID-19 mRNA vaccination among adults aged 65 years and older: Two self-controlled studies in the U.S.评估 COVID-19 mRNA 疫苗接种在 65 岁及以上成年人中的潜在不良事件：美国的两项自身对照研究
Vaccine. 2023 Jul 19;41(32):4666-4678. doi: 10.1016/j.vaccine.2023.06.014. Epub 2023 Jun 14.
5
Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Children Aged 5-11 Years - United States, October 12-January 1, 2023.5-11 岁儿童接种二价 COVID-19 mRNA 疫苗加强针的安全性监测-美国，2023 年 10 月 12 日-1 月 1 日。
MMWR Morb Mortal Wkly Rep. 2023 Jan 13;72(2):39-43. doi: 10.15585/mmwr.mm7202a5.
6
Booster dose of COVID-19 mRNA vaccine does not increase risks of myocarditis and pericarditis compared with primary vaccination: New insights from the vaccine adverse event reporting system.与基础免疫相比，COVID-19 mRNA 疫苗加强针不会增加心肌炎和心包炎的风险：疫苗不良事件报告系统的新见解。
Front Immunol. 2022 Sep 12;13:938322. doi: 10.3389/fimmu.2022.938322. eCollection 2022.
7
Post-vaccination adverse reactions, decision regret, and willingness to pay for the booster dose of COVID-19 vaccine among healthcare workers: A mediation analysis.接种后不良反应、决策后悔与医护人员对 COVID-19 疫苗加强针的支付意愿：中介分析。
Hum Vaccin Immunother. 2022 Nov 30;18(6):2146964. doi: 10.1080/21645515.2022.2146964. Epub 2022 Nov 24.
8
Medically Attended Acute Adverse Events in Pregnant People After Coronavirus Disease 2019 (COVID-19) Booster Vaccination.COVID-19 加强针接种后孕妇的医疗性急性不良事件
Obstet Gynecol. 2023 Jul 1;142(1):125-129. doi: 10.1097/AOG.0000000000005241. Epub 2023 May 9.
9
Adverse events following third dose of mRNA COVID-19 vaccination among nursing home residents who received the primary series.接种 mRNA COVID-19 疫苗后第三针后，养老院居民的不良事件，这些居民接受了基础系列疫苗接种。
J Am Geriatr Soc. 2022 Jun;70(6):1642-1647. doi: 10.1111/jgs.17812. Epub 2022 Apr 27.
10
Relative effectiveness of booster vs. 2-dose mRNA Covid-19 vaccination in the Veterans Health Administration: Self-controlled risk interval analysis.在退伍军人健康管理局中，加强针与 2 剂 mRNA COVID-19 疫苗接种的相对有效性：自我对照风险间隔分析。
Vaccine. 2022 Aug 5;40(33):4742-4747. doi: 10.1016/j.vaccine.2022.06.047. Epub 2022 Jun 21.
引用本文的文献
1
Pemphigus and Bullous Pemphigoid Following COVID-19 Vaccination: A Systematic Review.新型冠状病毒肺炎疫苗接种后的天疱疮和大疱性类天疱疮：一项系统评价
Viruses. 2024 Dec 9;16(12):1896. doi: 10.3390/v16121896.
2
The Past, the Present and the Future of Teledermatology: A Narrative Review.远程皮肤病学的过去、现在与未来：一篇叙述性综述
Clin Cosmet Investig Dermatol. 2024 Mar 21;17:717-723. doi: 10.2147/CCID.S462799. eCollection 2024.
3
Pityriasis Rosea and Pityriasis Rosea-Like Eruption Following COVID-19 Vaccination: A Narrative Review.新型冠状病毒肺炎疫苗接种后玫瑰糠疹及玫瑰糠疹样皮疹：一项叙述性综述
Clin Cosmet Investig Dermatol. 2024 Jan 8;17:51-57. doi: 10.2147/CCID.S447834. eCollection 2024.
4
Herpes Zoster and COVID-19 Vaccination: A Narrative Review.带状疱疹与新冠病毒疫苗接种：一篇叙述性综述
Clin Cosmet Investig Dermatol. 2023 Nov 16;16:3323-3331. doi: 10.2147/CCID.S441898. eCollection 2023.
5
Guselkumab, Risankizumab, and Tildrakizumab in the Management of Hidradenitis Suppurativa: A Review of Existing Trials and Real-Life Data.古塞库单抗、司库奇尤单抗和替拉珠单抗治疗化脓性汗腺炎：现有试验及真实世界数据综述
Clin Cosmet Investig Dermatol. 2023 Sep 18;16:2525-2536. doi: 10.2147/CCID.S418748. eCollection 2023.
6
New Onset and Exacerbation of Psoriasis Following COVID-19 Vaccination: A Review of the Current Knowledge.新冠病毒疫苗接种后银屑病的新发与加重：当前知识综述
Biomedicines. 2023 Aug 3;11(8):2191. doi: 10.3390/biomedicines11082191.
7
Biologics for the Management of Erythrodermic Psoriasis: An Updated Review.用于红皮病型银屑病治疗的生物制剂：最新综述
Clin Cosmet Investig Dermatol. 2023 Aug 4;16:2045-2059. doi: 10.2147/CCID.S407813. eCollection 2023.
8
The Impact of COVID-19 Vaccination on Inflammatory Skin Disorders and Other Cutaneous Diseases: A Review of the Published Literature.COVID-19 疫苗接种对炎症性皮肤疾病和其他皮肤疾病的影响：已发表文献综述。
Viruses. 2023 Jun 23;15(7):1423. doi: 10.3390/v15071423.
9
Teledermatology for Common Inflammatory Skin Conditions: The Medicine of the Future?常见炎症性皮肤病的远程皮肤病学：未来医学？
Life (Basel). 2023 Apr 18;13(4):1037. doi: 10.3390/life13041037.
10
Safety and Efficacy of Covid-19 Vaccination in Patients Undergoing Biological Treatments for Psoriasis.新冠病毒疫苗在接受生物制剂治疗的银屑病患者中的安全性和有效性。
Psoriasis (Auckl). 2023 Apr 12;13:11-18. doi: 10.2147/PTT.S398135. eCollection 2023.
本文引用的文献
1
Cutaneous adverse reactions following SARS-CoV-2 vaccine booster dose: a real-life multicentre experience.新型冠状病毒2型疫苗加强针接种后的皮肤不良反应：一项真实世界多中心经验
J Eur Acad Dermatol Venereol. 2022 Nov;36(11):e876-e879. doi: 10.1111/jdv.18386. Epub 2022 Jul 10.
2
Reply to 'Cutaneous adverse effects of the available COVID-19 vaccines in India: A questionnaire-based study' by Bawane J et al.对Bawane J等人所著的《印度现有新冠疫苗的皮肤不良反应：一项基于问卷调查的研究》的回复
J Eur Acad Dermatol Venereol. 2022 Nov;36(11):e863-e864. doi: 10.1111/jdv.18341. Epub 2022 Jun 30.
3
Cutaneous reactions following booster dose administration of COVID-19 mRNA vaccine: A first look from the American Academy of Dermatology/International League of Dermatologic Societies registry.新型冠状病毒肺炎mRNA疫苗加强剂量接种后的皮肤反应：来自美国皮肤病学会/国际皮肤病学协会联盟注册处的初步观察
JAAD Int. 2022 Sep;8:49-51. doi: 10.1016/j.jdin.2022.04.004. Epub 2022 Apr 26.
4
Teledermatology: A useful tool also after COVID-19 era?远程皮肤病学：在新冠疫情时代之后也是一种有用的工具吗？
J Cosmet Dermatol. 2022 Jun;21(6):2309-2310. doi: 10.1111/jocd.14938. Epub 2022 Apr 11.
5
Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study.BNT162b2 mRNA COVID-19 疫苗加强针在预防以色列重症结局的有效性：一项观察性研究。
Lancet. 2021 Dec 4;398(10316):2093-2100. doi: 10.1016/S0140-6736(21)02249-2. Epub 2021 Oct 29.
Zotero 插件